For HCPs Only
Recent Clinical Updates
Loading latest clinical updates
TABLET, EXTENDED RELEASE

FDA Drug Reference

Arthritis Pain

Generic: Acetaminophen

Dosage Form

TABLET, EXTENDED RELEASE

Route

ORAL

NDC

68196-034

This page summarizes official FDA drug label records for professional reference. Verify prescribing decisions against the complete current label and institutional policy.

Label Record Status

Data from U.S. Food and Drug Administration label records. Listing expiration: Date unavailable

Clinical Pharmacology

Indications & Usage

Arthritis Pain is listed as a TABLET, EXTENDED RELEASE formulation in the TABLET, EXTENDED RELEASE category. Consult official FDA labeling for full prescribing information.

Administration Context

Arthritis Pain is administered via the ORAL route as a TABLET, EXTENDED RELEASE.

Administration Protocol

Prescribing Information

Refer to official FDA labeling or institutional protocols for complete dosage and administration instructions.

Safety Profile

Contraindications & Warnings

Consult the official FDA-approved labeling for complete contraindications, warnings, precautions, and patient-specific safety information.

National Drug Registry

Product and label metadata.

Marketing Category

ANDA

Route of Administration

ORAL

National Drug Code

68196-034

Manufacturer / Labeler

SAM'S WEST INC

Dosage Form

TABLET, EXTENDED RELEASE

Strength

See labeling

Application Number

ANDA215486

SPL Identifier

3c156540-3319-441d-e063-6394a90adced

WHO Regulatory Intelligence

Vaccine Safety Information

Access evidence-based safety data and clinical guidelines from global health resources.

View Vaccine Safety